title: Histologic classification of thymic epithelial tumors: comparison of established classification schemes.
abstract: The object of our multicenter retrospective study was to compare the new histologic World Health Organization (WHO) classification and the classical histologic Bernatz classification in terms of interobserver agreement and prognostic importance. The influence of coexisting diseases was also analyzed using the Charlson score. We evaluated 218 patients from 5 different hospitals who were treated between 1967 and 1998. The statistical methods of analysis included Kaplan-Meier estimates of survival curves and the application of Cox proportional hazards models to identify sets of prognostic factors for survival. Interobserver agreement was assessed by kappa coefficients. For both WHO and Bernatz classifications, interobserver agreement was good (weighted kappa > 0.87). However, the subdiversification of the "bioactive" WHO subgroup (B1, B2, B3) resulted in an interobserver agreement of only 0.49 within this group. In multivariable models, both the WHO classification and the Bernatz classification including carcinomas showed similar prognostic capabilities. The B3 type in the WHO classification and the predominantly epithelial type in the Bernatz classification had an intermediate prognostic ranking in comparison with the carcinomas and with the other subgroups. For both classifications, further simplification and subclassification into 3 subgroups led to classes with good discriminative power in respect to survival. In addition, very good interobserver agreement was observed in the simplified classifications. Comorbidity, sex, age of the patient and lymphofollicular hyperplasia had no major influence on overall survival. Both classifications showed similar prognostic power. Interobserver agreement of the type B subgroups was only moderate. By simplification of the classifications, subgroups with distinct survival could be identified.
authors.affiliation: Department of Pathology, University of Heidelberg, Heidelberg, Germany. ralf_rieker@med.uni-heidelberg.de
authors.forename: Ralf J
authors.initials: RJ
authors.lastname: Rieker
authors.forename: Josef
authors.initials: J
authors.lastname: Hoegel
authors.forename: Alicia
authors.initials: A
authors.lastname: Morresi-Hauf
authors.forename: Walter J
authors.initials: WJ
authors.lastname: Hofmann
authors.forename: Hendrik
authors.initials: H
authors.lastname: Blaeker
authors.forename: Roland
authors.initials: R
authors.lastname: Penzel
authors.forename: Herwart F
authors.initials: HF
authors.lastname: Otto
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000145:classification* / Q000473:pathology; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009375:Neoplasms, Glandular and Epithelial / Q000145:classification* / Q000473:pathology; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D013953:Thymus Neoplasms / Q000145:classification* / Q000473:pathology; D014944:World Health Organization